Literature DB >> 18488039

Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.

Thomas A Bowden1, A Radu Aricescu, Robert J C Gilbert, Jonathan M Grimes, E Yvonne Jones, David I Stuart.   

Abstract

Nipah and Hendra viruses are emergent paramyxoviruses, causing disease characterized by rapid onset and high mortality rates, resulting in their classification as Biosafety Level 4 pathogens. Their attachment glycoproteins are essential for the recognition of the cell-surface receptors ephrin-B2 (EFNB2) and ephrin-B3 (EFNB3). Here we report crystal structures of both Nipah and Hendra attachment glycoproteins in complex with human EFNB2. In contrast to previously solved paramyxovirus attachment complexes, which are mediated by sialic acid interactions, the Nipah and Hendra complexes are maintained by an extensive protein-protein interface, including a crucial phenylalanine side chain on EFNB2 that fits snugly into a hydrophobic pocket on the viral protein. By analogy with the development of antivirals against sialic acid binding viruses, these results provide a structural template to target antiviral inhibition of protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18488039     DOI: 10.1038/nsmb.1435

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  110 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Structure of the measles virus hemagglutinin bound to the CD46 receptor.

Authors:  César Santiago; María L Celma; Thilo Stehle; José M Casasnovas
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

3.  A convenient and general expression platform for the production of secreted proteins from human cells.

Authors:  Halil Aydin; Farshad C Azimi; Jonathan D Cook; Jeffrey E Lee
Journal:  J Vis Exp       Date:  2012-07-31       Impact factor: 1.355

4.  Structural principles within the human-virus protein-protein interaction network.

Authors:  Eric A Franzosa; Yu Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-16       Impact factor: 11.205

5.  Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.

Authors:  Jinhui Dong; Robert W Cross; Michael P Doyle; Nurgun Kose; Jarrod J Mousa; Edward J Annand; Viktoriya Borisevich; Krystle N Agans; Rachel Sutton; Rachel Nargi; Mahsa Majedi; Karla A Fenton; Walter Reichard; Robin G Bombardi; Thomas W Geisbert; James E Crowe
Journal:  Cell       Date:  2020-12-10       Impact factor: 41.582

Review 6.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

7.  JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2012-07-27       Impact factor: 3.616

Review 8.  Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Authors:  Ponraj Prabakaran; Zhongyu Zhu; Xiaodong Xiao; Arya Biragyn; Antony S Dimitrov; Christopher C Broder; Dimiter S Dimitrov
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

9.  Structural disorder within Henipavirus nucleoprotein and phosphoprotein: from predictions to experimental assessment.

Authors:  Johnny Habchi; Laurent Mamelli; Hervé Darbon; Sonia Longhi
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

10.  Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.

Authors:  Thomas A Bowden; A Radu Aricescu; Joanne E Nettleship; Christian Siebold; Nahid Rahman-Huq; Raymond J Owens; David I Stuart; E Yvonne Jones
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.